Related Experiment Videos
Single- and multistep resistance selection studies on the activity of retapamulin compared to other agents against
Klaudia Kosowska-Shick1, Catherine Clark, Kim Credito
1Department of Pathology, Hershey Medical Center, P.O. Box 850, Hershey, PA 17033, USA.
Abstract:
Retapamulin had the lowest rate of spontaneous mutations by single-step passaging and the lowest parent and selected mutant MICs by multistep passaging among all drugs tested for all Staphylococcus aureus strains and three Streptococcus pyogenes strains which yielded resistant clones. Retapamulin has a low potential for resistance selection in S. pyogenes, with a slow and gradual propensity for resistance development in S. aureus.
Insights
Retapamulin showed the lowest mutation rates against Staphylococcus aureus and Streptococcus pyogenes. This antibiotic has a low potential for developing resistance in these bacteria.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Antibiotic resistance is a growing global health threat.
- Novel therapeutic agents are needed to combat resistant bacterial infections.
- Understanding resistance development mechanisms is crucial for effective treatment strategies.
Purpose of the Study:
- To evaluate the potential for resistance selection of retapamulin.
- To compare retapamulin's resistance profile with other antimicrobial agents.
- To assess resistance development in Staphylococcus aureus and Streptococcus pyogenes.
Main Methods:
- Single-step and multistep passaging assays were employed.
- Minimum Inhibitory Concentrations (MICs) of parent and mutant strains were determined.
- Resistance selection potential was assessed across various bacterial strains.
Main Results:
- Retapamulin exhibited the lowest spontaneous mutation rate in single-step passaging.
- Lowest parent and selected mutant MICs were observed for retapamulin in multistep passaging.
- Retapamulin demonstrated a low propensity for resistance selection in Streptococcus pyogenes and a slow, gradual development in Staphylococcus aureus.
Conclusions:
- Retapamulin possesses a favorable resistance profile.
- The drug shows a low potential for rapid resistance development.
- Retapamulin is a promising agent for treating infections caused by Staphylococcus aureus and Streptococcus pyogenes.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Antimicrobial Effectiveness